Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+5.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$57.2B
AUM Growth
+$57.2B
(+0.97%)
Cap. Flow
-$11.2M
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,007
New
143
Increased
297
Reduced
383
Closed
137
Top Buys
| 1 |
ConocoPhillips
COP
|
$230M |
| 2 |
Bristol-Myers Squibb
BMY
|
$185M |
| 3 |
WESCO International
WCC
|
$171M |
| 4 |
Gilead Sciences
GILD
|
$158M |
| 5 |
Delta Air Lines
DAL
|
$148M |
Top Sells
| 1 |
MRO
Marathon Oil Corporation
MRO
|
$221M |
| 2 |
3M
MMM
|
$154M |
| 3 |
Marsh & McLennan
MMC
|
$115M |
| 4 |
Johnson & Johnson
JNJ
|
$99M |
| 5 |
Novo Nordisk
NVO
|
$94.6M |
Sector Composition
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Bally's
BALY
$489M
| – | – | -127,144 | Closed | -$2.19M |
|
927
Baxter International
BAX
$12.7B
| – | – | -1,563,567 | Closed | -$59.4M |
|
928
Brink's
BCO
$4.67B
| – | – | -20,839 | Closed | -$2.41M |
|
929
Franklin Resources
BEN
$13.3B
| – | – | -265,900 | Closed | -$5.36M |
|
930
Biogen
BIIB
$19.4B
| – | – | -45,799 | Closed | -$8.88M |
|
931
TopBuild
BLD
$11.8B
| – | – | -5,000 | Closed | -$2.03M |
|
932
BioNTech
BNTX
$24B
| – | – | -57,500 | Closed | -$6.83M |
|
933
Bolt Biotherapeutics
BOLT
$9.85M
| – | – | -500,000 | Closed | -$324K |
|
934
Perspective Therapeutics
CATX
$250M
| – | – | -750,000 | Closed | -$10M |
|
935
Century Aluminum
CENX
$2.08B
| – | – | -10,000 | Closed | -$162K |
|
936
Citizens Financial Group
CFG
$22.6B
| – | – | -62,619 | Closed | -$2.57M |
|
937
Campbell Soup
CPB
$9.52B
| – | – | -43,346 | Closed | -$2.12M |
|
938
Capri Holdings
CPRI
$2.45B
| – | – | -749,133 | Closed | -$31.8M |
|
939
CRH
CRH
$75.9B
| – | – | -222,000 | Closed | -$20.6M |
|
940
CervoMed
CRVO
$83.7M
| – | – | -28,600 | Closed | -$418K |
|
941
CytomX Therapeutics
CTMX
$336M
| – | – | -3,000,000 | Closed | -$3.54M |
|
942
Crane NXT
CXT
$3.43B
| – | – | -720,485 | Closed | -$40.4M |
|
943
CyberArk
CYBR
$22.8B
| – | – | -20,000 | Closed | -$5.83M |
|
944
Dominion Energy
D
$51.1B
| – | – | -265,811 | Closed | -$15.4M |
|
945
DocuSign
DOCU
$15.5B
| – | – | -25,000 | Closed | -$1.55M |
|
946
Darden Restaurants
DRI
$24.1B
| – | – | -43,604 | Closed | -$7.16M |
|
947
ESSA Pharma
EPIX
$11.4M
| – | – | -1,474,165 | Closed | -$8.93M |
|
948
Farmer Brothers
FARM
$43.1M
| – | – | -171,229 | Closed | -$339K |
|
949
Fate Therapeutics
FATE
$120M
| – | – | -870,000 | Closed | -$3.05M |
|
950
Shift4
FOUR
$6.21B
| – | – | -49,000 | Closed | -$4.34M |
|